课题基金 / 基金详情

项目摘要

项目成果

William P Fay的其他基金

相似基金

相关文献

中文摘要
翻译
该项目的目标是为创新的电子鼻系统建立强大的概念验证可行性, 称为MOF-SCENT系统,用于无症状和有症状的实时和非侵入性筛查 COVID-19患者,基于呼出气体中挥发性有机化合物的检测,具有很高的准确性。的 提出的基于OE-HCCR-MOF的电子鼻传感器是一种新颖的生物传感和化学传感技术, 由于灵敏度和选择性的提高,将从根本上推进电子鼻传感技术。
英文摘要
The goal of this project is to establish robust, proof-of-concept feasibility for an innovative E-nose system, termed the MOF-SCENT system, for real-time and non-invasive screening for asymptomatic and symptomatic COVID-19 patients, with high accuracy based on the detection of VOCs emanating from exhaled breath. The proposed OE-HCCR-MOF based E-nose sensor is a novel biosensing and chemical sensing technology that will fundamentally advance E-nose sensing technologies due to the improved sensitivity and selectivity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Plasminogen Activator Inhibitor-1 in Vascular Smooth Muscle Cell Stiffening and Senescence
Role of Plasminogen Activator Inhibitor-1 in Vascular Smooth Muscle Cell Stiffening and Senescence
Midwest Biomedical Accelerator Consortium: MBArC
  • 批准号:
    10230468
  • 项目类别:
  • 资助金额:
    $117.16万
  • 财政年份:
    2020
  • 负责人:
    William P Fay
  • 依托单位:
Midwest Biomedical Accelerator Consortium: MBArC
  • 批准号:
    10475264
  • 项目类别:
  • 资助金额:
    $98.1万
  • 财政年份:
    2019
  • 负责人:
    William P Fay
  • 依托单位:
海外基金